GLPwatch
Trials (2081)
Page 20 of 35.
- Liraglutide in Newly Onset Type 1 Diabetes.
- A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
- GLP-1 and Microvascular Function in Type 2 Diabetes
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
- Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
- Impact of Exenatide on Sleep in Type 2 Diabetes
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes
- Improving Beta Cell Function in Mexican American Women With Prediabetes
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
- A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
- The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
- Antidiabetic Effects on Intrahepatic Fat
- Prognostic Predictors of Response to Hypoglycemic Therapy
- Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
- Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
- A Study of IBI362 in Chinese Patients With Type 2 Diabetes
- Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
- Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
- Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects
- SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes
- A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
- A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
- Liraglutide for Low-responders After Bariatric Surgery
- A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
- Liraglutide and Cardio-Metabolic Risk Markers
- Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
- Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data
- Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
- A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
- A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
- Treatment of GLP-1 for Diabetic Bariatric Patients
- A Study of a Novel Precision Medicine Approach For Obesity
- Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
- Tirzepatide in Obesity-Driven Endometrial Cancer
- Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
- Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM
- A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
- Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
- Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
- Separate and Combined Extrapancreatic Effects of GIP and GLP-1